Good SRH | ||||||||
Men | Women | |||||||
Model 1 | Model 2 | Model 1 | Model 2 | |||||
OR | 95% CI | OR | 95% CI | OR | 95% CI | OR | 95% CI | |
Total time effect | 1.38*** | 1.25–1.52 | 1.13* | 1.04–1.29 | 1.77*** | 1.63–1.98 | 1.34*** | 1.20–1.41 |
Direct time effect | 1.14* | 1.03–1.25 | 1.00 | 0.93–1.15 | 1.38*** | 1.26–1.52 | 1.15** | 1.03–1.28 |
Indirect time effect | 1.21*** | 1.19–1.24 | 1.13*** | 1.11–1.15 | 1.28*** | 1.24–1.31 | 1.17*** | 1.14–1.19 |
APE (%-points) | 95% CI | APE (%-points) | 95% CI | APE (%-points) | 95% CI | APE (%-points) | 95% CI | |
Total time effect | 7.3 | 5.1–9.4 | 2.7 | 0.9–5.7 | 12.4 | 10.4–14.4 | 6.8 | 4.5–9.1 |
Direct time effect | 2.9 | 0.7–5.1 | 0.0 | −1.6-3.1 | 7.1 | 5.0–9.2 | 3.5 | 1.2–5.9 |
Indirect time effect | 4.4 | ---a | 2.7 | --- a | 5.3 | --- a | 3.3 | --- a |
Conf_ratio | 2.5 | --- b | 1.7 | 2.1 | ||||
Conf_pct | 60.1 | 100.0 | 42.8 | 53.4 | ||||
Poor SRH | ||||||||
Men | Women | |||||||
Model 1 | Model 2 | Model 1 | Model 2 | |||||
OR | 95% CI | OR | 95% CI | OR | 95% CI | OR | 95% CI | |
Total time effect | 0.75*** | 0.67–0.84 | 1.04 | 0.91–1.18 | 0.72*** | 0.65–0.80 | 0.99 | 0.88–1.12 |
Direct time effect | 0.96 | 0.86–1.08 | 1.21** | 1.07–1.38 | 0.92 | 0.83–1.03 | 1.18** | 1.04–1.33 |
Indirect time effect | 0.79*** | 0.77–0.81 | 0.86*** | 0.84–0.88 | 0.78*** | 0.76–0.80 | 0.85*** | 0.83–0.87 |
APE (%-points) | 95% CI | APE (%-points) | 95% CI | APE (%-points) | 95% CI | APE (%-points) | 95% CI | |
Total time effect | −4.7 | −6.6-2.8 | 0.6 | −1.4-2.6 | −6.0 | −8.2-0.4 | −0.1 | −0.22-0.20 |
Direct time effect | −0.7 | −2.6-1.2 | 3.0 | 1.0–5.0 | −1.4 | −3.5-0.5 | 2.8 | 0.70–4.94 |
Indirect time effect | −4.0 | --- a | −2.4 | --- a | −4.6 | --- a | −2.9 | --- a |
Conf_ratio | 6.9 | --- c | 4.2 | --- c | ||||
Conf_pct | 85.5 | --- c | 76.3 | --- c |